390 results on '"Su, W.‐C."'
Search Results
2. A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer
3. Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
4. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
5. Flexible low-temperature polycrystalline silicon thin-film transistors
6. OA04.04 The Registry of Genetic Alterations of Taiwan NSCLC by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study - TCOG T1521 Study
7. The residual effects of bensulfuron-methyl on growth and photosynthesis of soybean and peanut
8. OA01.07 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations
9. PP01.48 Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in Locally Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) without EGFR-Activating Mutations
10. Framing Technologies in the Dramaturgies of Performance
11. Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
12. Effect of imazapic residues on photosynthetic traits and chlorophyll fluorescence of maize seedlings
13. LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial
14. MA13.07 TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC
15. EP08.02-029 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment
16. Deep Learning of Detecting Ionospheric Precursors Associated With M ≥ 6.0 Earthquakes in Taiwan
17. 987P Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study
18. Ca/Al of plagioclase-hosted melt inclusions as an indicator for post-entrapment processes at mid-ocean ridges?
19. Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy
20. Source of ore fluids in Carlin-type gold deposits, China: Implications for genetic models
21. Pre- and post-filtering approach to sensorless VSS speed control of a permanent magnet DC motor subject to Hammerstein and Wiener nonlinearities
22. Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
23. MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy
24. LBA2 Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab + atezolizumab (TA) versus placebo + atezolizumab (PA) as first-line treatment for PD-L1+ NSCLC
25. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer
26. Erratum: MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy
27. 1314MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)
28. The safety and efficacy of ipilimumab in patients with advanced melanoma in a Taiwanese cohort of the ipilimumab expanded access program: P080
29. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
30. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion
31. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
32. Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer
33. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation
34. Abelian decomposition method for G2 gauge theory
35. Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis
36. Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
37. Abelian decomposition of SO(2N) Yang-Mills theory
38. Sp1 expression regulates lung tumor progression
39. FRONT-LINE CONCURRENT CHEMORADIOTHERAPY (CCRT) FOLLOWED CONSOLIDATION CHEMOTHERAPY IN LOCALIZED NASAL NK/T-CELL LYMPHOMA
40. The pilA gene of Xanthomonas campestris pv. citri is required for infection by the filamentous phage cf
41. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease
42. 299MO Efficacy and safety of entrectinib in an Asian population with NTRK fusion-positive (fp) solid tumours or ROS1-fp NSCLC
43. LBA62 Efficacy and safety of patritumab deruxtecan (U3-1402), a novel HER3 directed antibody drug conjugate, in patients (pts) with EGFR-mutated (EGFRm) NSCLC
44. Recurrent Dynamics of Rupture Transitions of Single Giant Vesicles at Solid Surfaces
45. Wavelet‐based approach of time series model for modal identification of a bridge with incomplete input
46. Chronic hepatitis B patients have increased risk of gastroesophageal reflux disease in Taiwan
47. Gastrointestinal: Strangulated Meckelʼs diverticulum
48. Hepatobiliary and pancreatic: Gas-forming abscess after radiofrequency ablation for hepatocellular carcinoma
49. Hepatobiliary and pancreatic: Pancreatic ascites
50. Gastrointestinal: Bleeding gastric diverticulum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.